Clinical study to Evaluate The Efficacy Of Pippalyadi Churna With Ghrita In Oligomenorrhoea.

Randomized Open Labelled Controlled Clinical Study to Evaluate The Efficacy Of Pippalyadi Churna With Ghrita In Oligomenorrhoea. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104478

Enrollment

120

Registered

2026-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having primary or secondary Amenorrhea. Pregnant women, Lactating mothers, perimenopausal and menopausal women. Patients having PCOS with heavy menstrual bleeding and Hypogonadotropic, Hypogonadism, premature ovarian failure, and other pituitary ovarian syndrome. Patients take Oral Contraceptive Pills within 3 months, Hormonal therapy used for obesity and diabetes etc, taking radiation therapy within 3 years. Patients suffering from Endocrine disorders, Diabetic Mellitus, Thyroid dysfunction, Hyperprolactinemia, Cushing syndrome, Cardiovascular disorders Psychological, Epileptic disorders etc. Patients having Excessive menstrual bleeding disorders, systemic diseases like Tuberculosis, Anorectal bleeding, GIT tract Ulcers, STD Infections. Patients with any congenital anomalies, malignantlesions, obstructed and pelvic pathology in the reproductive system.

Exclusion criteria

Exclusion criteria: Patients having primary or secondary Amenorrhea. Pregnant women, Lactating mothers, perimenopausal and menopausal women. Patients having PCOS with heavy menstrual bleeding and Hypogonadotropic, Hypogonadism, premature ovarian failure, and other pituitary ovarian syndrome. Patients take Oral Contraceptive Pills within 3 months, Hormonal therapy used for obesity and diabetes etc, taking radiation therapy within 3 years. Patients suffering from Endocrine disorders, Diabetic Mellitus, Thyroid dysfunction, Hyperprolactinemia, Cushing syndrome, Cardiovascular disorders Psychological, Epileptic disorders etc. Patients having Excessive menstrual bleeding disorders, systemic diseases like Tuberculosis, Anorectal bleeding, GIT tract Ulcers, STD Infections. Patients with any congenital anomalies, malignantlesions, obstructed and pelvic pathology in the reproductive system.

Design outcomes

Primary

Measure	Time frame
Efficacy of Pippalyadi churna evaluated by interval between two menstrual cycle and amount of menstrual bleeding increases for 3 consecutive menstrual cycleTimepoint: 10 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactSoudamini Sudhir Chaudhari

Government Ayurved College Nanded

soudaminichaudhari@gmail.com09657017483

Outcome results